A novel 5-llipoxygenase inhibitor prevents gallstone formation in a lithogenic prairie dog model

American Surgeon

Volumn 62, Issue 7, 1996, Pages 551-555

  Kam, David M ^a   Webb, Phyllis A ^a   Sandman, Geoffrey ^a   Chugh, Aman ^a   Vertz, Mona L ^a   Scheeres, David E ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; ACETYLSALICYLIC ACID; CHOLESTEROL; LEUKOTRIENE; LIPOXYGENASE INHIBITOR;

ANIMAL MODEL; ARTICLE; CHOLELITHIASIS; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME INHIBITION; GALLSTONE FORMATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRECIPITATION; RODENT;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ASPIRIN; CHOLELITHIASIS; CHOLESTEROL; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; LEUKOTRIENES; MALE; SCIURIDAE;

EID: 0029887031     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Admirand WH, Small DM. The physico-chemical basis of cholesterol gallstone formation in man. J Clin Invest 1968;4:1043-52.
2. Donovan JM, Carey MC. Physico-chemical basis of gallstone formation. Gastroenterol Clin N AM 1991;20:61.
3. Conter RL, Washington JL, Liao C-C, Kauffman GL, Jr. Gallbladder mucosal blood flow increases during early cholesterol gallstone formation. Gastroenterology 1992;102:1764-70.
4. Dryer RL, Tammes AR, Routh JI. The determination of phosphorus and phosphatase with W-phenyl-p-phenylenediamine. J Biol Chem 1957;225:177-83.
5. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-55.
6. Saunders KD, Cates JA, Roslyn JJ. Pathogenesis of gallstones. Surg Clin North Am 1990;70:1197-1215.
7. Lee SP, Lim TH, Scott AJ. Role of gallbladder mucous hypersecretion in the evolution of cholesterol gallstones. Studies in the prairie dog. J Clin Invest 1981;67:1712-23.
8. Levy PF, Smith BF, LaMont JT. Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile. Gastroenterology 1984;87:270-5.
9. Lee SP, LaMont JT, Carey MC. Aspirin prevention of cholesterol gallstone formation in the prairie dog. Science 1981;211: 1429-32.
10. LaMont JT, Turner BS, DiBenedetto D, et. al. Arachidonic acid stimulates mucin secretion in prairie dog gallbladder. Am J Physiol 1983;245 (Gastrointest Liver Physiol 8): G92-8.
11. LaMorte WW, Booker ML, Scott TE, Williams LF, Jr. Increases in gallbladder prostaglandin synthesis before the formation of cholesterol gallstones. Surgery 1985;98:445-51.
12. LaMorte WW, LaMont JT, Hale W, et al. Gallbladder prostaglandins and lysophospholipids as mediators of mucin secretion during cholelithiasis. Am J Physiol 1986;251 (Gastrointest Liver Physiol 13): G701-9.
13. Samuelsson B, Dahlen S-E, Lindgren JA, et al. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 1987;237:1171-6.
14. Kaminski DL. Arachidonic acid metabolites in hepatobiliary physiology and disease. Gastroenterology 1989;97:781-92.
15. Hagmann W, Denzlinger C, Keppler D. Role of peptide leukotrienes and hepatobiliary elimination in endotoxin shock. Circ Shock 1984;14:223-5.
16. Keppler D, Hagmann W, Rupp S, et al. The relation of leukotrienes to liver injury. Hepatology 1985;5:883-91.
17. Leary DP, LaMorte WW, Scott TE, et al. Inhibition of prostaglandin synthesis fails to prevent gallbladder mucin hypersecretion in the cholesterol-fed prairie dog. Gastroenterology, 1991;101:812-20.
18. Harvey PR, Upadhya GA, Strasberg SM. Immunoglogulins as nucleating proteins in the gallbladder of patients with cholesterol gallstones. J Biol Chem 1991;266:13996-14003.
19. Lipsett PA, Hildreth J, Kaufman HS, et al. Human gallstones contain pronucleating nonmucin glycoproteins that are immunoglobulins. Ann Surg 1994;219:25-33.